Los Angeles, CA -- (SBWire) -- 05/28/2019 --Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
The classification of Darbepoetin Alfa includes Epogen, Procrit, Aranesp and others, and the proportion of Epogen in 2017 is about 45%.
Darbepoetin Alfa is widely used for Patients with Chronic Kidney Disease, Patients with Cancer others. The most proportion of Darbepoetin Alfa is used for the Patients with Chronic Kidney Disease, and the proportion in 2017 is 62%.
North America is the largest consumption place, with a consumption market share nearly 47% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 41%.
Get PDF of this report template: https://www.qyresearch.com/sample-form/form/956509/global-darbepoetin-alfa-market
This report focuses on Darbepoetin Alfa volume and value at global level, regional level and company level. From a global perspective, this report represents overall Darbepoetin Alfa market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Novartis
3SBio
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Epogen
Procrit
Aranesp
Others
Segment by Application
Patients with Chronic Kidney Disease
Patients with Cancer
Others
Get Customized Report in your Inbox within 24 hours @: https://www.qyresearch.com/customize-request/form/956509/global-darbepoetin-alfa-market
Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Darbepoetin Alfa Market by Type, Application, and Geography – Trends & Forecasts to 2019-2025: Amgen, Johnson & Johnson, Kyowa Hakko Kirin
QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.